Can Anaphylaxis Self-Resolve?
While some anaphylaxis episodes may resolve spontaneously without treatment, you should never withhold or delay epinephrine based on this possibility, as there is no way to predict which patients will progress to life-threatening or fatal reactions. 1
The Clinical Reality
The evidence acknowledges what clinicians sometimes observe: certain individuals do recover fully from anaphylaxis without receiving treatment 1. Anaphylaxis episodes exist on a spectrum—ranging from mild reactions that resolve spontaneously to those that prove fatal within minutes 2. The variations in symptom severity, trigger mechanisms, and individual mediator metabolism likely explain why some patients survive untreated episodes, though this phenomenon remains poorly understood 1.
Why This Should Never Guide Clinical Practice
The critical issue is that we cannot identify in the acute setting which individual patient is at risk for life-threatening or fatal anaphylaxis 1. This creates what the guidelines call the "anaphylaxis paradox"—patients may survive despite lack of treatment, yet delay in treatment is widely associated with death 1.
Key Practice Points:
- Mortality from anaphylaxis is remarkably low (<0.5% per episode), but when it occurs, delayed epinephrine is the common factor 1
- The well-recognized significant benefit from rapid epinephrine administration far outweighs any consideration of "waiting to see" if symptoms resolve 1
- Delaying epinephrine administration is associated with higher morbidity and mortality 1
The Evidence-Based Approach
The 2020 Joint Task Force Practice Parameter provides clear guidance 1:
- Administer epinephrine as first-line pharmacotherapy immediately when anaphylaxis is recognized
- Do not delay epinephrine administration—this is a good practice statement deemed essential for optimal patient outcomes
- Treatment should never be withheld for ongoing symptoms and should be advocated as best-practice strategy 1
Important Caveat
After initial epinephrine administration, if symptoms resolve promptly and caregivers are comfortable with observation, activation of emergency medical services may not be required in select cases 3. However, this applies only after epinephrine has been given, not as a strategy to avoid treatment.
The Bottom Line for Clinical Practice
Treat every anaphylaxis episode with prompt intramuscular epinephrine (0.01 mg/kg of 1:1000 solution, maximum 0.5 mg in adults, 0.3 mg in children) into the anterolateral thigh 1. The fact that some untreated episodes may resolve is a biological observation, not a clinical decision-making tool. There is no absolute contraindication to epinephrine use in anaphylaxis treatment 1.